ETHZilla Corporation (ETHZW)

NASDAQ: ETHZW · Real-Time Price · USD · Warrants
0.2000
0.00 (0.00%)
Sep 3, 2025, 10:59 AM - Market open
Market Cap444.89M
Revenue (ttm)n/a
Net Income (ttm)-17.22M
Shares Out 6.04M
EPS (ttm)-6.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume44,665
Open0.2306
Previous Close0.2000
Day's Range0.1904 - 0.2306
52-Week Range0.0031 - 0.6200
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateOct 23, 2025

About ETHZW

ETHZilla Corporation, a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases in the United States. The company product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren’s Contracture; and Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close ... [Read more]

Industry Biotechnology
Sector Healthcare
CEO Lloyd Jordan
Employees 4
Stock Exchange NASDAQ
Ticker Symbol ETHZW
Full Company Profile

News

There is no news available yet.